2021

SERAF, Oslo University Hospital, and Innlandet Hospital Trust researchers have recently published an article in Addiction on death among OAT patients in Norway. 

Researchers at OUS and SERAF have recently published an article on opioid treatment and follow-up after hospital discharge for patients following a serious accident and surgery at Norway's largest trauma center.

Researchers at Oslo University Hospital, SERAF and the Karolinska Institute have recently published an article on physical exercise as a part of drug treatment.

In a large cohort study, SERAF's Svetlana Skurtveit and others find a high prevalence of psychoactive drug use among trauma patients. 

SERAF researcher Svetlana Skurtveit has contributed to the publication of a national cohort study of opioid prescriptions for cancer patients. 

SERAF recently published the 2020 annual status report for opioid maintenance treatment (OMT).

Many inmates in Norwegian prisons are guilty of offenses that indicate drug use.

SERAF researchers have collaborated with colleagues in Denmark on a recently published article in Drug and Alcohol Dependence.

In a new article, SERAF researchers Desiree Eide and Thomas Clausen, in collaboration with King's College, suggest improvements to research methods regarding "take home" naloxone (THN).

In Norway naloxone nasal spray is distributed under the auspices of SERAF on behalf of the Norwegian Directorate of Health as part of a national overdose strategy (Nalokson.org). Naloxone nasal spray is an antidote treatment for opioid overdose.